You might notice less strength or stubborn fat, even with exercise
Unlike Wegovy, orforglipron has fewer restrictions around timing
Long-term users of retatrutide who also exercise regularly and have lost significant weight may find their resting heart rate actually lower than pre-treatment levels, because the cardiovascular benefits of weight loss and improved fitness outweigh the modest pharmacological heart rate increase
As we thoroughly collate and evaluate three years of studying GLP-1 obesity drug trends among real-world populations, new patterns are emerging that help us understand how these drugs are being used and how external factors may be impacting persistence and health outcomes, said Pat Gleason, PharmD, assistant vice president, health outcomes, at Prime
Dysesthesia occurred in 22.9% of participants at the 7.2mg dose versus only 6% at the 2.4mg dose and 0.5% with placebo
Neither compound produces both effects optimally